Le Lézard
Classified in: Oil industry, Business
Subject: CON

ORBITAL SIDEKICK TO MONITOR PIPELINE ASSETS FOR ENERGY TRANSFER USING SATELLITE TECHNOLOGY


Orbital Sidekick to provide pipeline monitoring services for compliance and leak detection

SAN FRANCISCO, June 23, 2022 /PRNewswire/ -- Orbital Sidekick (OSK) announced today it has been selected by Dallas-based Energy Transfer to monitor its assets in the Permian Basin through satellite technology. Energy Transfer is one of the largest energy infrastructure companies in North America with more than 120,000 miles of pipeline and related assets crossing 41 states. OSK is the first company to commercially deploy hyperspectral sensors in space.

Energy Transfer selected OSK to monitor its Permian Basin assets as part of its Partnership-wide pipeline integrity programs designed to ensure the continued safety of its pipelines. The use of OSK's satellite technology allows Energy Transfer to go above and beyond the minimum regulatory requirements in monitoring the integrity of its pipelines, something Energy Transfer has done for decades. OSK's satellite technology enables earlier detection and prevention of leaks along pipeline rights of way, using hyperspectral data analysis to drive broad improvements in community safety, environmental performance, and overall operating efficiency.

"Energy Transfer's selection of Orbital Sidekick is a testament to our asset monitoring solution addressing a real and emerging market need," Daniel Katz, CEO & Co-Founder of OSK, said. "Operators at Energy Transfer are able to assess the integrity of its pipelines daily, for a reasonable price point and in a more sustainable fashion." Further, Peter Weaver, OSK's Vice President of Business Development, said "Energy Transfer is an ideal partner to stretch our capabilities to meet the next level of industry demands."

Upon deployment of OSK's GHOSt constellation, beginning late 2022 / early 2023, OSK will offer frequent monitoring of pipeline assets to the global oil and gas industry through its SIGMA Platform. OSK's technology will help the industry meet its compliance & regulatory obligations as well as help transition towards more sustainable operations.

About Orbital Sidekick:

Orbital Sidekick's vision is to lead the Energy Transition by building the most robust remote sensing and analytics capability in existence. OSK's proprietary analytics platform and hyperspectral payload architecture provide persistent space-based monitoring solutions powered by Spectral IntelligenceTM. This unique radiometric speciation and change detection capability enables unparalleled target monitoring services for both commercial and defense users on a global scale. Orbital Sidekick is headquartered in San Francisco, California. For more information on Orbital Sidekick's global persistent monitoring services, please visit orbitalsidekick.com.

Press Contact:

Jack Buttacavoli
[email protected]

SOURCE Orbital Sidekick


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: